|
WO2021081470A1
|
|
Overlapping therapeutic strategies for cystinosis treatment and cosmetic skin darkening
|
|
WO2020243675A2
|
|
Compositions and methods for regulation of chronic toxoplasma infection
|
|
WO2020232416A1
|
|
Methods of characterizing and utilizing agent-condensate interactions
|
|
WO2020172338A1
|
|
Methods and agents for modulating mitochondrial nad levels
|
|
WO2020033498A1
|
|
Analogs of the natural product icariin
|
|
WO2019191148A1
|
|
Sideroflexins as mitochondrial serine transporters
|
|
EP3768329A2
|
|
Methods and assays for modulating gene transcription by modulating condensates
|
|
US2020347396A1
|
|
Biosynthetic Approach For Heterologous Production And Diversification Of Bioactive Lyciumin Cyclic Peptides
|
|
US2019271015A1
|
|
Enzymatic synthesis of kavalactones and flavokavains
|
|
US2019264221A1
|
|
Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2
|
|
US2019234942A1
|
|
METHODS OF IDENTIFYING MODULATORS OF SAMTOR-GATOR1 INTERACTION AND USE OF SAME TO MODULATE mTORC1
|
|
US2020206269A1
|
|
Production of enucleated red blood cells and uses thereof
|
|
US2020085817A1
|
|
Kcc2 expression enhancing compounds and uses thereof
|
|
US2020265917A1
|
|
Methods for building genomic networks and uses thereof
|
|
US2018353445A1
|
|
Methods and compositions relating to proteasome inhibitor resistance
|
|
US2019352648A1
|
|
Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
|
|
WO2018129544A1
|
|
Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
|
|
WO2018111944A1
|
|
Regulation of transcription through ctcf loop anchors
|
|
US2019352598A1
|
|
Human plasma-like medium
|
|
US2019249188A1
|
|
Modified Bialaphos Resistance Acetyltransferase Compositions And Uses Thereof
|
